Stock News

Rice Hall James & Associates Trimmed Its Globus Medical (GMED) Stake; Avnet (AVT) Shorts Down By 6.58%

Avnet Incorporated (NYSE:AVT) had a decrease of 6.58% in short interest. AVT’s SI was 4.67 million shares in January as released by FINRA. Its down 6.58% from 4.99M shares previously. With 812,400 avg volume, 6 days are for Avnet Incorporated (NYSE:AVT)’s short sellers to cover AVT’s short positions. The stock decreased 0.07% or $0.03 during the last trading session, reaching $41.75. About 971,193 shares traded or 12.06% up from the average. Avnet, Inc. (NYSE:AVT) has declined 4.87% since January 14, 2017 and is downtrending. It has underperformed by 21.57% the S&P500.

Rice Hall James & Associates Llc decreased Globus Medical Inc. (GMED) stake by 30.14% reported in 2017Q3 SEC filing. Rice Hall James & Associates Llc sold 249,698 shares as Globus Medical Inc. (GMED)’s stock rose 10.32%. The Rice Hall James & Associates Llc holds 578,716 shares with $17.20 million value, down from 828,414 last quarter. Globus Medical Inc. now has $4.21B valuation. The stock decreased 0.55% or $0.24 during the last trading session, reaching $43.66. About 695,406 shares traded. Globus Medical, Inc. (NYSE:GMED) has risen 30.88% since January 14, 2017 and is uptrending. It has outperformed by 14.18% the S&P500.

Avnet, Inc., together with its subsidiaries, distributes electronic components worldwide. The company has market cap of $5.05 billion. The firm operates through two divisions, Electronic Components and Premier Farnell. It has a 10.3 P/E ratio. The Electronic Components segment markets and sells semiconductors; electronic components, including interconnect, passive and electromechanical devices; and other integrated components from electronic component manufacturers.

Among 10 analysts covering Avnet Inc. (NYSE:AVT), 0 have Buy rating, 2 Sell and 8 Hold. Therefore 0 are positive. Avnet Inc. had 29 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was initiated by Bank of America on Wednesday, April 27 with “Neutral”. The firm has “Hold” rating by Stifel Nicolaus given on Thursday, October 26. The stock of Avnet, Inc. (NYSE:AVT) earned “Hold” rating by Deutsche Bank on Thursday, August 10. As per Thursday, September 22, the company rating was maintained by Citigroup. On Friday, April 29 the stock rating was downgraded by Brean Capital to “Hold”. Longbow upgraded the shares of AVT in report on Friday, January 22 to “Buy” rating. SunTrust maintained the stock with “Hold” rating in Wednesday, October 11 report. The stock of Avnet, Inc. (NYSE:AVT) has “Neutral” rating given on Friday, April 28 by Longbow. The stock has “Hold” rating by Suntrust Robinson on Friday, April 28. On Wednesday, August 9 the stock rating was maintained by Stifel Nicolaus with “Hold”.

Since August 17, 2017, it had 0 insider buys, and 1 insider sale for $393,260 activity. BIGGINS J VERONICA sold $393,260 worth of stock.

Investors sentiment increased to 0.99 in Q3 2017. Its up 0.15, from 0.84 in 2017Q2. It increased, as 31 investors sold Avnet, Inc. shares while 107 reduced holdings. 45 funds opened positions while 91 raised stakes. 112.60 million shares or 3.41% less from 116.57 million shares in 2017Q2 were reported. Gsa Cap Ptnrs Llp holds 0.03% in Avnet, Inc. (NYSE:AVT) or 11,075 shares. Sterling Cap Mngmt Lc holds 0% or 13,000 shares in its portfolio. Balyasny Asset Mgmt, Illinois-based fund reported 24,877 shares. 10,906 are held by Natixis Asset Mngmt. Point72 Asia (Hong Kong) owns 11 shares for 0% of their portfolio. Pzena Inv Management Limited Company has invested 1.69% in Avnet, Inc. (NYSE:AVT). Paragon Capital Management reported 5,774 shares. Cubist Systematic Strategies Limited Liability Corp invested 0.04% in Avnet, Inc. (NYSE:AVT). Nordea Mgmt owns 170,903 shares. Fdx Advisors Inc holds 0.02% or 14,193 shares in its portfolio. Tocqueville Asset Mgmt Limited Partnership holds 0.03% or 62,447 shares. Ledyard Bankshares holds 0.01% in Avnet, Inc. (NYSE:AVT) or 2,100 shares. Hightower Ltd Limited Liability Company holds 8,291 shares or 0% of its portfolio. State Street Corp reported 0.02% in Avnet, Inc. (NYSE:AVT). Schwab Charles Mgmt reported 0.02% in Avnet, Inc. (NYSE:AVT).

Analysts await Globus Medical, Inc. (NYSE:GMED) to report earnings on February, 26. They expect $0.34 EPS, up 9.68% or $0.03 from last year’s $0.31 per share. GMED’s profit will be $32.76 million for 32.10 P/E if the $0.34 EPS becomes a reality. After $0.30 actual EPS reported by Globus Medical, Inc. for the previous quarter, Wall Street now forecasts 13.33% EPS growth.

Investors sentiment decreased to 1.38 in Q3 2017. Its down 0.19, from 1.57 in 2017Q2. It is negative, as 18 investors sold GMED shares while 68 reduced holdings. 42 funds opened positions while 77 raised stakes. 64.77 million shares or 3.39% more from 62.65 million shares in 2017Q2 were reported. Invesco Ltd invested in 0% or 44,642 shares. Pnc Financial Svcs Group Inc stated it has 0% in Globus Medical, Inc. (NYSE:GMED). Bridgeway Cap Mgmt owns 19,300 shares. Minnesota-based Advantus Mgmt has invested 0.01% in Globus Medical, Inc. (NYSE:GMED). 49,867 are owned by Argent Capital Management Lc. National Bank & Trust Of Mellon Corporation reported 2.37 million shares or 0.02% of all its holdings. California State Teachers Retirement Sys has invested 0.01% in Globus Medical, Inc. (NYSE:GMED). Bank Of America De invested in 0% or 739,450 shares. Caxton Assoc Lp invested 0.02% in Globus Medical, Inc. (NYSE:GMED). Cantab Cap Prtnrs Llp invested 0.29% of its portfolio in Globus Medical, Inc. (NYSE:GMED). Gofen & Glossberg Ltd Il reported 76,848 shares. Tudor Et Al owns 7,736 shares. Mutual Of America Capital Mngmt Limited Co holds 0.03% of its portfolio in Globus Medical, Inc. (NYSE:GMED) for 56,758 shares. Balyasny Asset Limited Liability holds 11,874 shares. Morgan Stanley holds 315,119 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *